Effectiveness of high protein supplementation on muscle mass and function among older adults with sarcopenia
Not Applicable
Completed
- Conditions
- SarcopeniaDiet and Nutrition - Other diet and nutrition disordersMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12624000277549
- Lead Sponsor
- O Nutrition Malaysia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Aged 60 and above
Skeletal muscle index (SMI) <7.0kg/m2 (male) or <5.7kg/m2 (female)
Exclusion Criteria
Poorly controlled diabetes, chronic kidney disease stage 3a and below, gastrointestinal diseases, milk/soy intolerance or allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie high protein supplementation's effects on sarcopenia in ACTRN12624000277549?
How does high protein supplementation compare to standard-of-care exercise regimens for sarcopenia management?
Which biomarkers correlate with muscle mass improvement in sarcopenic older adults receiving protein supplementation?
What adverse events are associated with high protein intake in sarcopenia patients and how are they managed?
Are there synergistic effects when combining high protein supplementation with anabolic agents like GH or IGF-1 in sarcopenia treatment?